Pharmaceutical supply chain: first-mile logistics
Pharmaceuticals
Key takeaways
The pharmaceutical supply chain moves materials and finished medicines from suppliers and manufacturers through distribution to the pharmacies, hospitals and patients that use them.
The first mile runs from released product at the manufacturing site to the first carrier, and errors made there follow the shipment to its destination.
US requirements include written warehousing and distribution procedures, quality unit release, lot traceability for recalls and DSCSA obligations for covered prescription drugs.
Drug substances follow their own GMP storage and distribution expectations, and some also fall under hazardous materials rules.
Supply chain systems work only when each physical handoff is tied to an accurate record and a named owner.
The pharmaceutical supply chain is the network that moves raw materials, drug substances and finished medicines from suppliers and manufacturers through storage and distribution to the pharmacies, hospitals, clinics and patients who use them. Pharma supply chain management connects those physical movements with quality release, inventory, documentation and accountable handoffs, so that the right product arrives in usable condition and can be traced if something goes wrong.
The first mile is where that chain starts for a finished batch: the stretch from released product inside the manufacturing site to the first carrier that takes custody. It is short in distance and easy to underestimate, yet a gap in release status, packaging, paperwork or pickup timing at that point travels with the shipment to every later stage. This guide covers how the chain is structured, which requirements apply and six steps for planning first-mile logistics at a new or expanding site.
What is the pharmaceutical supply chain?
The pharmaceutical supply chain is the sequence of organizations and movements that turns materials into medicines and gets those medicines to the point of use. It includes suppliers of ingredients and components, manufacturers and packagers, warehouses and distribution centers, wholesale distributors, third-party logistics providers, carriers and dispensers such as pharmacies and hospitals.
Pharmaceutical supply chain logistics is the physical side of that network: storage, transport, handoffs and the records that prove each step. The World Health Organization's model guidance for storing and transporting time- and temperature-sensitive pharmaceutical products separates two parts of it. Internal distribution covers transport inside a manufacturer's own network, from manufacturing facility to packaging facility, warehouse and distribution center. External distribution covers movement from the manufacturer's distribution center to wholesalers, retailers, clinical facilities or patients.
That distinction matters because responsibility changes at each boundary. Inside the company, the manufacturer's quality system governs. Once product leaves for a third party, contracts, licenses and trading partner rules take over as well.
What are the stages of pharmaceutical logistics?
The stages of pharmaceutical logistics are inbound supply, manufacturing and release, first-mile dispatch, distribution, final delivery and reverse logistics. The table shows what moves at each stage and where custody changes hands.
Stage | What moves | Key handoff |
|---|---|---|
Inbound supply | Ingredients, drug substances, components, packaging | Supplier to manufacturer's receiving team |
Manufacturing and release | Work in progress, quarantined and released batches | Production to quality unit to warehouse |
First-mile dispatch | Released, packed and documented shipments | Manufacturer to first carrier |
Distribution | Finished product through depots and distributors | Carrier to wholesaler, 3PL or distribution center |
Final delivery | Orders for authorized recipients | Provider to pharmacy, hospital, clinic or patient |
Reverse logistics | Returns, recalls and samples | Recipient back to manufacturer or designated site |
Pharma distribution logistics usually means the middle two stages, but problems rarely respect that boundary. A missed pickup at the first mile can empty a distributor's stock days later, and a recall depends on records created at every stage. Mercury's article on chain of custody in life science logistics explains how those records connect.
What is the logistics process for couriering pharmaceuticals?
The logistics process for couriering pharmaceuticals starts when the shipper books the move with the collection and delivery addresses, ready time, delivery deadline, handling requirements and any hazardous materials classification. The courier confirms it can accept the commodity and lane, collects the prepared goods, records the handoff and milestones in transit, and delivers to a named, authorized recipient who signs for the package count. For urgent or high-value moves, the courier may use a dedicated vehicle, a same-day courier, a seat on the next available flight or a combination of legs. The right choice depends on the allowed transit time, security needs and what the provider can actually support.
What is first mile logistics in pharma?
First mile logistics in pharma is the movement of released product from the manufacturing or packaging site to the first transport provider, including staging, packing, documentation and pickup. Mercury's glossary entry on first mile logistics gives the general definition. In pharmaceuticals the first mile carries extra weight because it is where quality release, product protection and transport custody meet for the first time. Clinical trial material leaves the manufacturer the same way, though its later stages run to trial sites rather than commercial channels, as Mercury explains in its guide to clinical supplies management.
First mile delivery is not complete when a truck reaches the gate. The origin team and the driver should agree the package count, reference numbers, condition data and handoff time, and resolve any discrepancy before the shipment leaves. The six steps below turn that into a repeatable process.
Map the dispatch path and its conditions.
Connect quality release to physical dispatch.
Confirm traceability and trading partner obligations.
Select carriers and put responsibilities in writing.
Synchronize pickups with batch completion.
Build, test and own the backup plan.
Step 1: Map the dispatch path and its conditions
Walk the real route from finished-goods storage to the vehicle with production, warehouse, quality and transport staff. Note where released product waits, who moves it, how long loading takes and where it is exposed to dock conditions. WHO recommends profiling transport routes against the ambient conditions expected throughout the year and selecting equipment and containers using weather data and tests. A loading dock that is comfortable in spring may be the hottest point of the route in August. Set controls for each zone and document them in the site's procedures. For temperature-sensitive products, Mercury's guide to pharma cold chain logistics covers packaging and monitoring in detail.
Step 2: Connect quality release to physical dispatch
In the US, 21 CFR 211.22 gives the quality control unit the authority to approve or reject drug products, and 21 CFR 211.142 requires quarantine of drug products before that release. The dispatch process should make it impossible to load a batch that is still in quarantine. That means the warehouse system, the pick list and the shipping paperwork all need to show the same release status, and someone must check it before the driver signs.
Step 3: Confirm traceability and trading partner obligations
For prescription drugs within its scope, the Drug Supply Chain Security Act sets steps for an interoperable, electronic way to identify and trace products at the package level as they move through the supply chain. Each trading partner must be able to exchange the required product and transaction information with the next.
Check the current exemption status before assuming any extra time. As of its August 2026 update, the FDA's DSCSA exemptions page lists one exemption, for small dispensers and, where applicable, their trading partners, which runs until November 27, 2027. It lists none for manufacturers, repackagers, wholesale distributors or larger dispensers. A partner that cannot meet the requirements may request a waiver, exception or exemption, and FDA expects it to keep working toward compliance until the request is decided. Mercury's article on what pharmaceutical shippers must do for DSCSA in 2026 covers the practical steps.
Keep product tracing separate from carrier tracking. A pickup scan records a logistics milestone. It does not supply the transaction information a covered trading partner must provide.
Step 4: Select carriers and put responsibilities in writing
Choose carriers on capability for your product and lane, not only on rate. WHO advises that carriers moving temperature-sensitive products operate under a formal service level agreement that makes them responsible for maintaining the defined transport conditions, and that vehicle conformity with that agreement be checked before goods are loaded. Agree in writing who conditions packaging, who monitors in transit, who is called when a delay occurs and who keeps which records. Mercury's guide to selecting a life science logistics partner lists the questions to ask.
Step 5: Synchronize pickups with batch completion
A truck that arrives too early can be as harmful as one that arrives late. If the shipment is not packed, the vehicle waits or leaves, and product may sit longer outside controlled storage. Give the dispatcher a shipment-ready time, dock instructions and the latest collection that still meets the receiving window. Keep standing pickups for routine output and pre-agreed options for unplanned dispatches, such as next flight out or air freight when a schedule moves.
Step 6: Build, test and own the backup plan
New sites ramp up unevenly, so plan for volume swings and failures before the first batch ships. Name a secondary carrier for each critical lane and confirm it accepts the commodity. Identify where product can wait under approved conditions if a pickup fails. During onboarding, run one routine collection and one disruption scenario end to end, including document changes and notice to the recipient.
Start this work while the facility is being built. For new US drug manufacturing sites, FDA announced the FDA PreCheck program on August 7, 2025, describing a two-phase approach covering facility readiness and application submission. Logistics readiness should keep pace with that regulatory timeline so the first released batch has a tested route out of the building.
What are the requirements for pharmaceutical logistics?
Pharmaceutical logistics requirements depend on the product, the activity and the jurisdiction, but in the US a core set applies to most finished drugs. The list below summarizes the main ones. Treat it as a starting point and confirm the exact obligations with your quality and regulatory teams.
Written warehousing procedures. 21 CFR 211.142 requires quarantine before release and storage under conditions of temperature, humidity and light that protect identity, strength, quality and purity.
Written distribution procedures. 21 CFR 211.150 requires that the oldest approved stock is distributed first, with temporary and appropriate deviations allowed, and that the distribution of each lot can be readily determined to support a recall.
Quality unit release. Only product approved by the quality control unit should leave for distribution.
DSCSA compliance. Covered prescription drugs need package-level identification and tracing between trading partners.
Licensed partners. FDA states that wholesale drug distributors and third-party logistics providers must be appropriately licensed and report licensure and other information to FDA annually to be authorized trading partners.
Hazardous materials rules. Refrigerants such as dry ice, and some drug substances or solvents, can be hazardous materials in transport and then fall under the Hazardous Materials Regulations issued by PHMSA.
Pharmaceutical logistics management is the work of turning that list into procedures, contracts and checks that people follow every day. A requirement that lives only in a regulation summary will not stop a quarantined pallet from being loaded.
Drug substance logistics follows its own GMP expectations
Drug substance logistics covers active pharmaceutical ingredients and intermediates moving between manufacturing sites, contract manufacturers and fill-finish facilities. Section 10 of the ICH Q7 guideline on GMP for active pharmaceutical ingredients sets the expectations. APIs and intermediates should be released by the quality unit before distribution to third parties, though they can move under quarantine to another unit under the company's control when the quality unit authorizes it and controls are in place. They should be transported in a way that does not harm quality, special transport or storage conditions should be stated on the label, the transport contractor should know and follow those conditions, and the distribution of each batch should be traceable for recall.
Drug substances can also have hazard profiles that finished medicines do not. Check the safety data sheet for the transport classification before booking, and confirm the carrier accepts that class on the chosen mode.
How is the pharmaceutical supply chain managed?
The pharmaceutical supply chain is managed by combining procedures, systems and contracts so that every physical movement has an owner, a record and a defined response when something fails. Logistics in pharmaceutical industry settings is less about moving boxes than about keeping product status, location and condition in agreement at every handoff.
Pharma supply chain management systems
Pharma supply chain management systems typically include enterprise resource planning for orders and inventory, warehouse management for location and release status, transport management for bookings and tracking, and the systems used to exchange DSCSA data with trading partners. The common failure is not a missing system but two systems that disagree. Decide which system is authoritative for each field, such as release status, lot number or delivery time, and who acts when records conflict. Mercury's article on tracking life science shipments covers the transport visibility side.
Measure what the first mile actually delivers
Track confirmed pickups against the plan, complete handoff records and usable receipt at the next location, not only on-time delivery. A shipment that arrives on time with a missing logger file or a count discrepancy still creates work and risk downstream. Review repeat problems, such as one dock that always runs late, and change the process rather than paying for emergency upgrades.
Choosing pharmaceutical supply chain solutions and consulting
Pharmaceutical supply chain solutions can include route design, qualified packaging, transport management, storage and data exchange. Pharmaceutical supply chain consulting can help a new site find gaps before launch. In either case, the agreement should state which party approves release, maintains records, monitors shipments and makes quality decisions. Ask the provider to show how it would run your first dispatch, including the failure scenario, before go-live. Mercury's first mile logistics success story shows how one onboarding was structured.
Mercury supports clinical and commercial drug shippers with first-mile planning, scheduled and on-demand pickups and backup options across ground and air, starting from the product's requirements and the site's actual dispatch process.
